Skip to main content
Year archive

Arctic Bioscience — 2025 filings

All 92 regulatory filings released by Arctic Bioscience (ABS) in 2025, sourced directly from the official regulator.

92 Filings
2025 Period
2025 filings (92)
Filing Released Lang
Financial calendar
Report Publication Announcement
2025-12-18 English
Finansiell kalender
Report Publication Announcement
2025-12-18 Norwegian
Arctic Bioscience - Share capital increase registered
Share Issue/Capital Change
2025-12-17 English
Arctic Bioscience - Registrert aksjekapitalforhøyelse
Share Issue/Capital Change
2025-12-17 Norwegian
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldskonvertering - Attachment: 20251212_Statment_from_the_BoD_of_ABS.pdf
Share Issue/Capital Change
2025-12-12 Norwegian
Arctic Bioscience - Board approval of share capital increase related to conversion of debt - Attachment: 20251212_Statment_from_the_BoD_of_ABS.pdf
Share Issue/Capital Change
2025-12-12 Norwegian
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldskonvertering - Attachment: 20251212_Minutes_from_Board_Meeting.pdf
Share Issue/Capital Change
2025-12-12 Norwegian
Arctic Bioscience - Board approval of share capital increase related to conversion of debt - Attachment: 20251212_Minutes_from_Board_Meeting.pdf
Share Issue/Capital Change
2025-12-12 Norwegian
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldskonvertering
Share Issue/Capital Change
2025-12-12 Norwegian
Arctic Bioscience - Board approval of share capital increase related to conversion of debt
Share Issue/Capital Change
2025-12-12 English
Arctic Bioscience - Protokoll fra ekstraordinær generalforsamling - Attachment: 20251111_ABS_Minutes_from_Extraord_General_Meeting.pdf
Declaration of Voting Results & Voting Rights Announcements
2025-11-11 Norwegian
Arctic Bioscience - Minutes of the Extraordinary General Meeting - Attachment: 20251111_ABS_Minutes_from_Extraord_General_Meeting.pdf
Declaration of Voting Results & Voting Rights Announcements
2025-11-11 Norwegian
Arctic Bioscience - Protokoll fra ekstraordinær generalforsamling
AGM Information
2025-11-11 Norwegian
Arctic Bioscience - Minutes of the Extraordinary General Meeting
AGM Information
2025-11-11 English
Arctic Bioscience - Q3 2025 Operational update - Significant results on systemic inflammation - Attachment: 20251110_ABS_Results_Q325_Presentation.pdf
Investor Presentation
2025-11-10 English
Arctic Bioscience - 3. kvartal 2025 operasjonell oppdatering - Signifikante effekter på systemisk inflammasjon - Attachment: 20251110_ABS_Results_Q325_Presentation.pdf
Investor Presentation
2025-11-10 English
Arctic Bioscience - Q3 2025 Operational update - Significant results on systemic inflammation
Earnings Release Q3 2025
2025-11-10 English
Arctic Bioscience - 3. kvartal 2025 operasjonell oppdatering - Signifikante effekter på systemisk inflammasjon
Interim / Quarterly Report Q3 2025
2025-11-10 Norwegian
Arctic Bioscience - Invitation to presentation of Q3 operational update and HeROPA-analyses results
Report Publication Announcement
2025-11-07 English
Arctic Bioscience - Invitasjon til presentasjon av Q3 operasjonell oppdatering og resultater fra HeROPA-analyser
Report Publication Announcement
2025-11-07 Norwegian
Arctic Bioscience - Analyse av HeROPA-studien viser statistisk signifikante effekter av HRO350 på betennelse - Attachment: Attachm_Analysis_details_and_results.pdf
Investor Presentation Q4 2025
2025-11-04 English
Arctic Bioscience - Analysis on HeROPA study shows statistically significant effects of psoriasis drug candidate HRO350 on inflammation - Attachment: Attachm_Analysis_details_and_results.pdf
Regulatory Filings
2025-11-04 English
Arctic Bioscience - Analyse av HeROPA-studien viser statistisk signifikante effekter av HRO350 på betennelse
Regulatory Filings
2025-11-04 Norwegian
Arctic Bioscience - Analysis on HeROPA study shows statistically significant effects of psoriasis drug candidate HRO350 on inflammation
Regulatory Filings
2025-11-04 English
Arctic Bioscience - Innkalling til ekstraordinær generalforsamling 11. november 2025 - Attachment: 20251028_ABS_Notice_EGM_11_11_2025.pdf
Proxy Solicitation & Information Statement
2025-10-28 Norwegian
Arctic Bioscience - Notice of Extraordinary General Meeting on 11 November 2025 - Attachment: 20251028_ABS_Notice_EGM_11_11_2025.pdf
Proxy Solicitation & Information Statement
2025-10-28 Norwegian
Arctic Bioscience - Innkalling til ekstraordinær generalforsamling 11. november 2025
AGM Information
2025-10-28 Norwegian
Arctic Bioscience - Notice of Extraordinary General Meeting on 11 November 2025
AGM Information
2025-10-28 English
Arctic Bioscience - Stable development with upside potential - Attachment: ABS_Presentation_H1_2025.pdf
Investor Presentation
2025-08-28 English
Arctic Bioscience - Stabil utvikling med oppsidepotensial - Attachment: ABS_Presentation_H1_2025.pdf
Investor Presentation
2025-08-28 English
Arctic Bioscience - Stable development with upside potential - Attachment: ABS_Half_year_report_2025.pdf
Interim / Quarterly Report H1 2025
2025-08-28 English
Arctic Bioscience - Stabil utvikling med oppsidepotensial - Attachment: ABS_Half_year_report_2025.pdf
Interim / Quarterly Report H1 2025
2025-08-28 English
Arctic Bioscience - Stable development with upside potential
Earnings Release H1 2025
2025-08-28 English
Arctic Bioscience - Stabil utvikling med oppsidepotensial
Interim / Quarterly Report H1 2025
2025-08-28 Norwegian
Arctic Bioscience - Invitation to presentation of half year 2025 results
Report Publication Announcement
2025-08-21 English
Arctic Bioscience - Invitasjon til presentasjon av halvårsresultat for 2025
Report Publication Announcement
2025-08-21 Norwegian
Arctic Bioscience - Signifikant synsforbedring i klinisk grønn stær-studie
Regulatory Filings
2025-08-18 Norwegian
Arctic Bioscience - Achieves significant vision improvement in Clinical Glaucoma Study
Regulatory Filings
2025-08-18 English
Arctic Bioscience lanserer nytt hudpleieprodukt - Romega Skin Refine
Regulatory Filings
2025-08-12 Norwegian
Arctic Bioscience launches new skin care product - Romega Skin Refine
Regulatory Filings
2025-08-12 English
Arctic Bioscience - 12-month data confirm potential for HRO350 in mild-to-moderate psoriasis - Attachment: Presentation_HeROPA_12_month_read_out.pdf
Investor Presentation
2025-07-01 English
Arctic Bioscience - 12-måneders data bekrefter potensialet for HRO350 i mild til moderat psoriasis - Attachment: Presentation_HeROPA_12_month_read_out.pdf
Investor Presentation
2025-07-01 English
Arctic Bioscience - 12-month data confirm potential for HRO350 in mild-to-moderate psoriasis
Regulatory Filings
2025-07-01 English
Arctic Bioscience - 12-måneders data bekrefter potensialet for HRO350 i mild til moderat psoriasis
Earnings Release Q2 2025
2025-07-01 Norwegian
Arctic Bioscience - Minutes of the Annual General Meeting - Attachment: 20250526_ABS_Minutes_from_Ordinary_General_Meeting.pdf
AGM Information
2025-05-26 Norwegian
Arctic Bioscience - Protokoll fra ordinær generalforsamling - Attachment: 20250526_ABS_Minutes_from_Ordinary_General_Meeting.pdf
AGM Information
2025-05-26 Norwegian
Arctic Bioscience - Minutes of the Annual General Meeting
AGM Information
2025-05-26 English
Arctic Bioscience - Protokoll fra ordinær generalforsamling
AGM Information
2025-05-26 Norwegian
Arctic Bioscience - Q1 2025 Operational update - Growth-platform established
Interim / Quarterly Report Q1 2025
2025-05-15 English
Arctic Bioscience - 1. kvartal 2025 operasjonell oppdatering - Vekstplattform etablert
Earnings Release Q1 2025
2025-05-15 Norwegian
Arctic Bioscience - Registrert aksjekapitalforhøyelse
Share Issue/Capital Change
2025-05-12 Norwegian
Arctic Bioscience - Share capital increase registered
Share Issue/Capital Change
2025-05-12 English
Arctic Bioscience - Innkalling til ordinær generalforsamling 26. mai 2025
AGM Information
2025-05-12 Norwegian
Arctic Bioscience - Notice of Annual General Meeting on 26 May 2025
AGM Information
2025-05-12 Norwegian
Arctic Bioscience - Innkalling til ordinær generalforsamling 26. mai 2025
AGM Information
2025-05-12 Norwegian
Arctic Bioscience - Notice of Annual General Meeting on 26 May 2025
AGM Information
2025-05-12 English
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldskonvertering
Share Issue/Capital Change
2025-05-08 Norwegian
Arctic Bioscience - Board approval of share capital increase related to conversion of debt
Share Issue/Capital Change
2025-05-08 Norwegian
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldskonvertering
AGM Information
2025-05-08 Norwegian
Arctic Bioscience - Board approval of share capital increase related to conversion of debt
AGM Information
2025-05-08 Norwegian
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldskonvertering
Capital/Financing Update
2025-05-08 Norwegian
Arctic Bioscience - Board approval of share capital increase related to conversion of debt
Share Issue/Capital Change
2025-05-08 English
Arctic Bioscience - Annual report 2024
Annual Report FY 2024
2025-05-07 English
Arctic Bioscience - Årsrapport 2024
Annual Report FY 2024
2025-05-07 English
Arctic Bioscience - Annual report 2024
Report Publication Announcement
2025-05-07 English
Arctic Bioscience - Årsrapport 2024
Report Publication Announcement
2025-05-07 Norwegian
Arctic Bioscience - Exercise of right to convert debt and issuance of shares
Share Issue/Capital Change
2025-04-28 English
Arctic Bioscience - Utøvelse av rett til gjeldskonvertering og utstedelser av aksjer
Capital/Financing Update
2025-04-28 Norwegian
Arctic Bioscience announces encouraging top-line results from the HeROPA clinical study
Earnings Release Q2 2024
2025-04-24 English
Arctic Bioscience - HeROPA 1-års utlesning: Topplinjeresultater forventes innen 2-3 uker
Regulatory Filings
2025-04-01 Norwegian
Arctic Bioscience - HeROPA 1-year read-out: Top-line results expected within 2-3 weeks
Regulatory Filings
2025-04-01 English
Arctic Bioscience - 4. kvartal 2024 operasjonell oppdatering - Sterk avslutning på 2024
Investor Presentation
2025-02-27 English
Arctic Bioscience - Q4 2024 Operational update - Strong ending to 2024
Investor Presentation
2025-02-27 English
Arctic Bioscience - 4. kvartal 2024 operasjonell oppdatering - Sterk avslutning på 2024
Earnings Release Q4 2024
2025-02-27 Norwegian
Arctic Bioscience - Q4 2024 Operational update - Strong ending to 2024
Earnings Release Q4 2024
2025-02-27 English
Arctic Bioscience - Invitation to presentation of Q4 2024 operational update
Report Publication Announcement
2025-02-20 English
Arctic Bioscience - Invitasjon til presentasjon av operasjonell oppdatering for 4. kvartal 2024
Report Publication Announcement
2025-02-20 Norwegian
Arctic Bioscience - Share capital increase registered
Share Issue/Capital Change
2025-02-10 English
Arctic Bioscience - Registrert aksjekapitalforhøyelse
Share Issue/Capital Change
2025-02-10 Norwegian
Arctic Bioscience - Board approval of share capital increase related to conversion of debt
Capital/Financing Update
2025-02-03 Norwegian
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldskonvertering
Capital/Financing Update
2025-02-03 Norwegian
Arctic Bioscience - Board approval of share capital increase related to conversion of debt
AGM Information
2025-02-03 Norwegian
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldskonvertering
AGM Information
2025-02-03 Norwegian
Arctic Bioscience - Board approval of share capital increase related to conversion of debt
Share Issue/Capital Change
2025-02-03 English
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldskonvertering
Capital/Financing Update
2025-02-03 Norwegian
Arctic Bioscience - Utøvelse av rett til gjeldskonvertering og utstedelser av aksjer
Share Issue/Capital Change
2025-01-30 Norwegian
Arctic Bioscience - Exercise of right to convert debt and issuance of shares
Capital/Financing Update
2025-01-30 English
Arctic Bioscience - Joint Venture with Kotler to develop China and other SE Asian markets
M&A Activity
2025-01-21 English
Arctic Bioscience - Primærinnsideres deltakelse i konvertibel lånefasilitet
Director's Dealing
2025-01-13 Norwegian
Arctic Bioscience - Primary insiders participating in convertible loan facility
Director's Dealing
2025-01-13 English
Arctic Bioscience - finansiert til positiv kontantstrøm
Capital/Financing Update
2025-01-13 Norwegian
Arctic Bioscience - funded to cash positive
Capital/Financing Update
2025-01-13 English